DOX-SL: Began three Phase II trials

Liposome Technology Inc. (LTIZ), Menlo Park, Calif. Product: DOX-SL stealth liposome formulation of doxorubicin Indication: Ovarian, breast, and soft tissue cancers Status: Began three Phase II trials...